如何治疗儿童静脉血栓栓塞症
儿童静脉血栓栓塞症(VTE)发病率近十年显著上升,主要与中心静脉导管使用增加及危重患儿救治技术进步相关。由于大规模临床试验尚未完成,当前管理决策多依据成人数据外推和医生经验。本文描述作者处理3种常见儿童血栓场景的经验,并提供3个流程辅助管理决策。
要点
- 儿童VTE发病率近十年显著上升,多数患儿存在严重基础疾病。
- 大规模临床试验尚未完成,管理决策多基于成人数据外推和医生经验。
- 作者提供3个流程辅助儿童血栓管理决策。
核心结论
- 儿童VTE管理复杂,在临床试验结果可用之前,日常管理更多是艺术而非科学。
研究设计与样本
- 本文为「如何治疗」类综述,描述作者处理3种常见儿童血栓场景的经验并提供3个流程。
主要发现
- 儿童VTE发病率近十年显著上升,部分因对该严重疾病认识提高,更多因中心静脉导管使用增加及危重患儿救治技术进步。
- 绝大多数发生VTE的儿童存在严重基础疾病。
- 与成人相比儿童VTE仍相对罕见,大规模临床试验尚未完成。
临床怎么用
- 作者描述其处理3种常见儿童血栓场景的经验,并建议合理方法。
- 作者提供3个流程帮助指导管理决策。
局限性
- 大规模临床试验尚未完成,管理决策基于成人数据外推和主治医生经验,两者均存在明显问题。
- 日常管理更多是艺术而非科学,直至临床试验结果可用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The incidence of pediatric venous thromboembolism (VTE) has been increasing significantly over the past decade in part as a result of increased recognition of this serious disorder but more so because of the increased use of central venous catheters and other technological advancements involved in the care of ill children. Management of pediatric VTE is a complex undertaking, considering that the vast majority of children who develop this complication have serious underlying medical disorders. Although the incidence is rising, in comparison with adults, this remains a relatively rare disorder, and as such, large-scale clinical trials have not been completed, rendering management decisions to be based on extrapolation from adult data and the experience of the treating physician. Clearly, both are fraught with problems. Thus, day-to-day management remains more art than science until such time that the results from clinical trials (many of which are under way) become available. This edition of "How I Treat" describes the author's experience in managing 3 common scenarios that one may encounter in pediatric thrombosis and suggests a logical approach to such situations. Furthermore, the author provides 3 algorithms to help guide management decisions.
引用
- Young G. How I treat pediatric venous thromboembolism. Blood. 2017. PMID: 28774877. doi:10.1182/blood-2017-04-742320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。